Literature DB >> 10223344

Site-specific fluorescence labelling of recombinant polyomavirus-like particles.

U Schmidt1, J Kenklies, R Rudolph, G Böhm.   

Abstract

For the development of gene therapy protocols based on polyomavirus-like particles, we describe a method for fluorescence labelling of virions in order to study virus-cell interactions preceding gene delivery. Site-specific fluorescence labelling of polyomavirus-like particles is achieved via a single cysteine residue and maleimide conjugates of fluorescence dyes (fluorescein, Texas Red). Polyomavirus-like particles can be assembled in vitro from recombinant capsomers produced in E. coli. Since the assembly process is independent of disulfide bond formation, all cysteine residues of the wild-type protein were replaced by serines, and a new unique cysteine residue was introduced for the attachment of the fluorescence marker.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223344     DOI: 10.1515/BC.1999.053

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

1.  Coupling of antibodies via protein Z on modified polyoma virus-like particles.

Authors:  S Gleiter; H Lilie
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

2.  Mechanism of assembly of recombinant murine polyomavirus-like particles.

Authors:  U Schmidt; R Rudolph; G Böhm
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles.

Authors:  K Stubenrauch; S Gleiter; U Brinkmann; R Rudolph; H Lilie
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

4.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.